Suchergebnisse - "Libertínová, Jana"

PubPharm (6)

1

Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries

enthalten in: Multiple sclerosis and related disorders | 2023

von Hrnciarova, T. | Drahota, J. | Spelman, T. | +18

2

Is breastfeeding in MS harmful or not? An answer from real-world Czech data

enthalten in: Multiple sclerosis and related disorders | 2023

von Hradilek, P. | Zapletalova, O. | Hanulikova, P. | +18

3

IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis

enthalten in: PloS one | 2022

von Petržalka, M. | Meluzínová, E. | Libertínová, J. | +8

4

Elevated D-dimer as an immediate response to alemtuzumab treatment

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2021

von Libertinova, J. | Meluzinova, E. | Nema, E. | +7

5

MxA mRNA decrease preceding NAb detection in IFNβ-treated MS patients

enthalten in: Brain and behavior | 2017

von Libertinova, J. | Meluzinova, E. | Matoska, V. | +7

6

Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNβ

enthalten in: PloS one | 2017

von Libertinova, J. | Meluzinova, E. | Tomek, A. | +12

1
[1]